KEGG: gga:423422
UniGene: Gga.22630
The UPF0694 transmembrane protein C14orf109 homolog (RCJMB04_5b13) from Gallus gallus (chicken) is a multi-pass transmembrane protein with 131 amino acids in its expression region. Its amino acid sequence is: MMNFRQRMGWIGVGLYLLASAAAFYYVFEINETYNKLALEHIQQHPQEPQEGTTWTHSLKVRLLSLPFWLWTIIFLIPYLQMFLFLYSCTRADPKTVGYCIIPICLAVICNRHQTFVKASNQISRLQLIDT .
The protein likely participates in intracellular transport or signaling functions based on comparative analysis with homologs in other species. When studying this protein's structure, researchers should consider its transmembrane topology, which can be predicted using algorithms like TMHMM or Phobius to identify membrane-spanning regions. For experimental structure determination, techniques such as X-ray crystallography and cryo-electron microscopy present challenges due to the protein's membrane-embedded nature. Alternative approaches include NMR spectroscopy of reconstituted protein in membrane mimetics or targeted crosslinking experiments to validate predicted topology models.
For optimal stability and activity of recombinant Chicken UPF0694 transmembrane protein, researchers should implement the following methodological approaches:
Storage conditions: Store the protein at -20°C for regular use, or at -80°C for extended storage periods to minimize degradation .
Buffer composition: The protein is typically provided in a Tris-based buffer containing 50% glycerol as a cryoprotectant to prevent freeze-thaw damage .
Aliquoting strategy: To prevent repeated freeze-thaw cycles, divide the stock solution into single-use aliquots before freezing. For working stocks, maintain aliquots at 4°C for up to one week .
Reconstitution method: When using lyophilized protein, reconstitute in sterile deionized water. For enhanced stability during long-term storage, add glycerol to a final concentration of 5-50%.
Temperature transitions: Allow frozen protein to thaw completely at 4°C before use, avoiding rapid temperature changes that can cause protein aggregation.
When designing experiments, incorporate stability controls to verify protein integrity throughout the experimental timeline, as membrane proteins are particularly susceptible to denaturation and aggregation during handling procedures.
The selection of an appropriate expression system for recombinant UPF0694 transmembrane protein requires careful consideration of several methodological factors:
Bacterial expression systems: E. coli-based cell-free expression systems are commonly used for initial production attempts due to their simplicity and cost-effectiveness. When using bacterial systems, consider codon optimization for the chicken sequence and fusion tags (His, GST) to enhance solubility and facilitate purification.
Eukaryotic expression systems: For proper post-translational modifications and folding, yeast (S. cerevisiae or P. pastoris) or mammalian cell lines (HEK293, CHO) may provide superior results. These systems are particularly important if the protein's function depends on glycosylation or specific membrane lipid environments.
Expression strategy comparison:
| Expression System | Advantages | Limitations | Recommended Application |
|---|---|---|---|
| E. coli | High yield, cost-effective | Limited PTMs, inclusion body formation | Initial structural studies |
| Yeast | Moderate PTMs, high density cultures | Different glycosylation pattern | Functional studies requiring proper folding |
| Mammalian cells | Native-like PTMs and folding | Lower yield, higher cost | Advanced functional assays, protein-protein interactions |
| Cell-free systems | Rapid, toxicity not an issue | Limited PTMs, higher cost | Initial screening, difficult-to-express variants |
Solubilization approach: Regardless of the expression system, extraction from membranes requires careful optimization of detergents or amphipols to maintain the protein's native structure during purification.
Verification methods: Confirm proper expression and folding through Western blotting, circular dichroism, and functional assays before proceeding with downstream applications.
A comprehensive validation strategy for recombinant UPF0694 transmembrane protein should employ multiple complementary techniques:
Sequence verification: Confirm protein identity through mass spectrometry analysis, specifically liquid chromatography-tandem mass spectrometry (LC-MS/MS) with tryptic digestion, matching peptide fragments to the expected sequence (MMNFRQRMGWIGVGLYLLASAAAFYYVFEINETYNKLALEHIQQHPQEPQEGTTWTHSLKVRLLSLPFWLWTIIFLIPYLQMFLFLYSCTRADPKTVGYCIIPICLAVICNRHQTFVKASNQISRLQLIDT) .
Immunological confirmation: Develop or obtain antibodies specific to conserved epitopes of UPF0694 transmembrane protein for Western blot analysis. This approach can leverage the high sequence conservation among species homologs.
Purity assessment: Implement a multi-method approach:
SDS-PAGE with Coomassie or silver staining (≥95% purity standard)
Size exclusion chromatography to detect aggregates or degradation products
Dynamic light scattering to evaluate size distribution and homogeneity
Functional validation: Develop activity assays based on predicted functions (e.g., membrane transport, protein-protein interactions) to confirm that the purified protein retains its biological activity.
Structural integrity: Use circular dichroism spectroscopy to verify secondary structure elements expected for a transmembrane protein, particularly alpha-helical content typical of membrane-spanning domains.
When reporting results, researchers should document all validation methods used and establish clear acceptance criteria for each parameter measured to ensure reproducibility across studies.
The evolutionary conservation of UPF0694 transmembrane protein across diverse species provides valuable insights for researchers:
Phylogenetic distribution: Homologs of UPF0694 transmembrane protein exist across multiple vertebrate species including chicken, bovine, human, mouse, and zebrafish, suggesting fundamental biological importance. This conservation pattern indicates selective pressure to maintain protein function throughout vertebrate evolution.
Comparative sequence analysis:
| Species | Protein Name | Key Features | Sequence Identity to Chicken (%) |
|---|---|---|---|
| Chicken (Gallus gallus) | UPF0694 transmembrane protein C14orf109 homolog | Full sequence known (131 aa), Uniprot: Q5ZLR7 | 100% |
| Bovine (Bos taurus) | TMEM251 | Partial (1-163), Multi-pass membrane protein | ~75% |
| Human | C14orf109 | Full-length, Multiple isoforms | ~78% |
| Mouse | Tmem251 | Partial sequence known | ~76% |
Functional implications: The high degree of conservation suggests essential cellular functions, potentially in fundamental processes like:
Membrane trafficking or transport
Cell signaling pathways
Maintenance of cellular homeostasis
Structural roles in specific cellular compartments
Research applications: Evolutionary conservation provides several methodological advantages:
Enables cross-species extrapolation of functional data
Allows identification of critical functional domains through sequence alignment
Facilitates the use of model organisms for functional studies
Helps predict protein interactions based on conserved binding motifs
Computational approach: Researchers should employ multiple sequence alignment tools (MUSCLE, CLUSTAL) followed by conservation analysis (ConSurf, Rate4Site) to identify highly conserved residues likely essential for function, generating testable hypotheses for mutagenesis studies.
Designing robust experiments to elucidate the function of UPF0694 transmembrane protein requires systematic application of experimental design principles:
Variable definition and hypothesis formulation: Begin by clearly defining your research variables :
Independent variables: Protein expression levels, mutant variants, environmental conditions
Dependent variables: Cellular phenotypes, protein localization, interaction partners
Extraneous variables: Cell type differences, expression system artifacts, tag interference
Experimental design framework:
| Approach | Methodology | Advantages | Limitations |
|---|---|---|---|
| Loss-of-function | CRISPR/Cas9 knockout, siRNA knockdown | Direct assessment of necessity | Potential compensation mechanisms |
| Gain-of-function | Overexpression systems, inducible expression | Reveals sufficiency for phenotype | Potential artifacts from non-physiological levels |
| Structure-function | Site-directed mutagenesis of conserved residues | Links sequence to function | Requires prior knowledge of important residues |
| Localization studies | Fluorescent protein fusions, immunofluorescence | Identifies subcellular context | Tags may interfere with function |
Controls and randomization: Implement rigorous control systems :
Positive controls: Well-characterized related transmembrane proteins
Negative controls: Empty vector, non-targeting siRNA
Randomization: Assign samples randomly to treatment groups to minimize bias
Between-subjects vs. within-subjects design: For cell-based assays, utilize a between-subjects design with multiple biological replicates. For biochemical characterization, employ within-subjects design with technical replicates of the same protein preparation .
Validation strategy: Confirm findings through:
Multiple experimental approaches targeting the same question
Rescue experiments following knockdown/knockout
Replication in different cell types or model systems
When publishing results, clearly document all experimental parameters, statistical approaches, and negative findings to facilitate reproducibility and comprehensive understanding of UPF0694 transmembrane protein function .
Deciphering the membrane topology of UPF0694 transmembrane protein requires a multi-faceted methodological approach:
Computational prediction as starting point: Begin with in silico analysis using multiple transmembrane prediction algorithms (TMHMM, HMMTOP, Phobius) to generate initial topology models. The amino acid sequence (MMNFRQRMGWIGVGLYLLASAAAFYYVFEINETYNKLALEHIQQHPQEPQEGTTWTHSLKVRLLSLPFWLWTIIFLIPYLQMFLFLYSCTRADPKTVGYCIIPICLAVICNRHQTFVKASNQISRLQLIDT) suggests multiple membrane-spanning regions .
Experimental validation techniques:
| Technique | Methodology | Resolution | Advantages | Limitations |
|---|---|---|---|---|
| Protease protection assays | Selective proteolysis of accessible regions | Domain-level | Simple setup, biochemical validation | Low resolution |
| Glycosylation mapping | Insertion of glycosylation sites at predicted loops | Residue-level | In vivo analysis | Potential disruption of structure |
| Cysteine scanning mutagenesis | Systematic replacement with cysteine followed by accessibility labeling | Residue-level | High resolution | Labor-intensive |
| FRET/BRET analysis | Fluorescent/bioluminescent tags at termini or loops | Domain-level | Live-cell compatible | Potential tag interference |
| Cryo-EM | Single-particle analysis of purified protein | Atomic-level | Highest resolution | Technically challenging |
Experimental design considerations:
Expression system selection: Mammalian cells provide native-like membrane environment
Detergent selection: Critical for maintaining native structure during purification
Tag placement: Strategic positioning to minimize functional interference
Controls: Include well-characterized membrane proteins with known topology
Data integration strategy: Combine data from multiple approaches to develop a consensus topology model:
Reconcile conflicting data through additional targeted experiments
Weight evidence based on methodological strengths and limitations
Refine models iteratively as new data becomes available
Functional correlation: Link topology findings to functional hypotheses by identifying conserved motifs in specific membrane-spanning domains or loops that might participate in transport, signaling, or protein-protein interactions.
Reconciling contradictory data is a critical challenge in scientific research, particularly for poorly characterized proteins like UPF0694 transmembrane protein. A systematic approach to addressing contradictions includes:
Context analysis framework: Apply structured analysis to identify potential sources of apparent contradictions :
Experimental conditions: Different temperatures, pH, buffer compositions
Biological context: Species differences, tissue specificity, developmental stage
Methodological variations: Different expression systems, tags, or analytical techniques
Incomplete reporting: Underspecified parameters in published methods
Contradiction categorization: Classify contradictions to guide resolution strategies :
| Contradiction Type | Example in UPF0694 Research | Resolution Approach |
|---|---|---|
| Semantic contradictions | Different nomenclature (TMEM251 vs. C14orf109) | Standardize terminology, use unique identifiers (UniProt: Q5ZLR7) |
| Methodological contradictions | Different localization with different tags | Compare methodology details, evaluate tag interference |
| Biological contradictions | Different phenotypes in different cell types | Investigate tissue-specific regulatory mechanisms |
| Temporal contradictions | Different expression patterns at different stages | Design time-course experiments |
Data normalization strategy: Develop standardized protocols for:
Protein expression and purification
Functional assays
Data reporting and sharing
Computational integration: Apply computational approaches to formally represent contradictions :
Knowledge graphs to visualize conflicting claims
Bayesian inference to weight evidence quality
Meta-analysis of multiple datasets
Collaborative resolution: Establish research collaborations to:
Replicate key experiments across laboratories
Share reagents and protocols
Develop consensus experimental standards
When publishing research on UPF0694 transmembrane protein, explicitly address known contradictions in the literature, propose explanations for discrepancies, and design experiments specifically to resolve them .
Investigating protein-protein interactions (PPIs) for membrane proteins like UPF0694 transmembrane protein presents unique challenges requiring specialized methodological approaches:
Comprehensive interaction discovery strategy:
| Technique | Methodology | Detection Principle | Advantages | Limitations |
|---|---|---|---|---|
| Proximity-dependent biotin labeling (BioID/TurboID) | Fusion with biotin ligase to label proximal proteins | Mass spectrometry identification of biotinylated proteins | Works in native membrane environment, captures transient interactions | Cannot distinguish direct from indirect interactions |
| Membrane yeast two-hybrid | Modified Y2H system for membrane proteins | Transcriptional reporter activation | Designed specifically for membrane proteins | Artificial yeast membrane environment |
| Co-immunoprecipitation with crosslinking | Chemical crosslinking before solubilization | Antibody-based precipitation | Preserves native interactions | Requires specific antibodies, potential artifacts |
| FRET/BRET | Fluorescent/bioluminescent protein fusions | Energy transfer between interaction partners | Live-cell analysis, quantitative | Limited to tagged protein pairs |
| Surface plasmon resonance | Immobilized protein on sensor chip | Refractive index change upon binding | Quantitative binding parameters | Requires purified proteins, artificial environment |
Sample preparation considerations:
Membrane solubilization: Select detergents that maintain protein structure (e.g., DDM, LMNG)
Crosslinking optimization: Test multiple crosslinkers with varying spacer lengths
Expression levels: Maintain near-physiological levels to avoid artifactual interactions
Subcellular fractionation: Isolate relevant membrane compartments to reduce background
Validation hierarchy:
Primary screen: High-throughput methods (BioID, AP-MS)
Secondary validation: Orthogonal methods (co-IP, FRET)
Functional validation: Mutagenesis of interaction interfaces, functional assays
Bioinformatic integration:
Evolutionary analysis: Co-evolution patterns suggesting interaction partners
Domain analysis: Identification of known interaction motifs
Network analysis: Integration with existing protein interaction networks
Experimental design for transmembrane interactions:
Strategic truncation constructs to identify interaction domains
Competition assays to test binding specificity
Lipid dependency analysis to assess environmental requirements
Given the evolutionary conservation of UPF0694, interactions identified in one species should be systematically tested in homologs from other species to distinguish conserved from species-specific interaction networks.
Leveraging the evolutionary conservation of UPF0694 transmembrane protein provides powerful insights into its function through comparative analysis:
Systematic comparative framework:
| Analytical Approach | Methodology | Research Application | Expected Outcome |
|---|---|---|---|
| Sequence conservation mapping | Multiple sequence alignment, conservation scoring | Identification of functional domains | Prioritized targets for mutagenesis |
| Structural homology modeling | Threading of sequence onto solved structures of distant homologs | Prediction of 3D structure | Structural basis for function prediction |
| Synteny analysis | Examination of genomic context across species | Identification of functionally related genes | Potential pathway associations |
| Expression pattern comparison | Transcriptomic analysis across species | Identification of conserved regulatory mechanisms | Tissue-specific functions |
| Phenotypic comparison | Functional studies in multiple model organisms | Validation of conserved functions | Distinction between core and species-specific roles |
Strategic model organism selection:
Select diverse species with UPF0694 homologs: zebrafish, mouse, Xenopus
Leverage the experimental advantages of each model system
Design parallel experiments to test conserved hypotheses
Functional domain identification strategy:
Evolutionary rate analysis:
Calculate substitution rates across different protein regions
Identify domains under purifying selection (slow evolution)
Correlate evolutionary rates with predicted functional importance
Translation to functional hypotheses:
Generate testable hypotheses based on conserved features
Design complementation experiments across species
Evaluate functional redundancy with paralogous proteins
This comparative approach enables researchers to distinguish between core functions conserved through evolution and species-specific adaptations, providing a comprehensive understanding of UPF0694 transmembrane protein biology while maximizing the translational relevance of findings across species.